GLP-1 receptor agonists (semaglutide, liraglutide) are MHRA-approved for weight management and work by regulating appetite through mimicking glucagon-like peptide-1 hormone
Fundamental to all these projects is we want to make the delivery of this drug affordable, comfortable, and possible to do at home, says Daniell
B12 increases metabolism, which can help with weight loss
Here's how they compare: Semaglutide (GLP-1 agonist) Mechanism: Single-action GLP-1 receptor agonist FDA status: Approved for type 2 diabetes and chronic weight management Expected weight loss: 15-20% of body weight in clinical trials Administration: Once-weekly injection Best for: Patients starting their weight loss journey seeking proven, well-studied medication Tirzepatide (dual GIP/GLP-1 agonist) Mechanism: Targets both GIP and GLP-1 receptors for enhanced metabolic effect FDA status: Approved for type 2 diabetes and chronic weight management Expected weight loss: Up to 22% of body weight in clinical trials Administration: Once-weekly injection Best for: Patients seeking more aggressive fat loss with dual-action metabolic support Retatrutide (triple agonist, not yet available) Mechanism: Targets GLP-1, GIP, and glucagon receptors FDA status: Not FDA-approved
Sci Rep 7:12814
Now, they exist as lucrative black-market solutions to men who want the alleged benefits of Gwyneth Paltrows goop without the pastel colours